To further investigate the correlation between expression levels and disease severity, we divided 45 SLE patients into phenotype-positive and phenotype-negative groups according to the clinical parameters ESR, CRP, SSA52, AHA, snRNP, and anti-Smith antibody. The gene discussed is LSM2; the disease is systemic lupus erythematosus.